Clinical Trials Browser

Phase 2 × Adenoma, Islet Cell × Interferons × Clear all

NCT00001228 2017-07-02

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Phase 2 Completed

Adenoma, Islet Cell, Zollinger-Ellison Syndrome